Erratum: Mast Cells Are Required for Full Expression of Allergen/SEB-Induced Skin Inflammation (S0022202X15360668 (2013) 133(12) (2695–2705) (S0022202X15360668) (10.1038/jid.2013.250));Mast cells are required for full expression of allergen/SEB-Induced skin inflammation

Journal of Investigative Dermatology

Volumn 133, Issue 12, 2013, Pages 2695-2705

  Ando, Tomoaki ^a   Matsumoto, Kenji ^b   Namiranian, Siavash ^c   Yamashita, Hirotaka ^a   Glatthorn, Haley ^a   Kimura, Miho ^a,g   Dolan, Brandon R ^a   Lee, James J ^d   Galli, Stephen J ^e   Kawakami, Yuko ^a   Jamora, Colin ^c   Kawakami, Toshiaki ^a,f  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^b NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d MAYO GRADUATE SCHOOL   (United States)

^e STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f RIKEN Center for Integrative Medical Sciences   (Japan)

^g KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; EPIDERMAL GROWTH FACTOR; FC EPSILON RECEPTOR I; FC RECEPTOR; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E RECEPTOR; STAPHYLOCOCCUS ENTEROTOXIN B; THYMIC STROMAL LYMPHOPOIETIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CELL COUNT; CONTROLLED STUDY; DERMATITIS; DERMATOPHAGOIDES FARINAE; DIFFERENTIATION; DISEASE SEVERITY; ENERGY METABOLISM; EOSINOPHIL; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENE EXPRESSION PROFILING; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; LIPID METABOLISM; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TH2 CELL;

EID: 84887822093     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2014.359     Document Type: Erratum

References (71)

1. Abboud G, Staumont-Salle D, Kanda A et al. (2009) Fc(epsilon)RI and FcgammaRIII/CD16 differentially regulate atopic dermatitis in mice. J Immunol 182:6517-26
2. Alenius H, Laouini D, Woodward A et al. (2002) Mast cells regulate IFN-gamma expression in the skin and circulating IgE levels in allergen-induced skin inflammation. J Allergy Clin Immunol 109:106-13
3. Allakhverdi Z, Comeau MR, Jessup HK et al. (2007) Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells. J Exp Med 204:253-8
4. Al-Shami A, Spolski R, Kelly J et al. (2004) A role for thymic stromal lymphopoietin in CD4() T cell development. J Exp Med 200:159-68
5. Amrol D (2010) Anti-immunoglobulin e in the treatment of refractory atopic dermatitis. South M J 103:554-8
6. Asai K, Kitaura J, Kawakami Y et al. (2001) Regulation of mast cell survival by IgE. Immunity 14:791-800
7. Barnes KC (2010) An update on the genetics of atopic dermatitis: scratching the surface in 2009. J Allergy Clin Immunol 125:16-29
8. Belloni B, Andres C, Ollert M et al. (2008) Novel immunological approaches in the treatment of atopic eczema. Curr Opin Allergy Clin Immunol 8:423-7
9. Bieber T (2008) Atopic dermatitis. N Engl J Med 358:1483-94
10. Bogiatzi SI, Fernandez I, Bichet JC et al. (2007) Cutting edge: proinflammatory and Th2 cytokines synergize to induce thymic stromal lymphopoietin production by human skin keratinocytes. J Immunol 178:3373-7
11. Boguniewicz M, Leung DY (2011) Atopic dermatitis: a disease of altered skin barrier and immune dysregulation. Immunol Rev 242:233-46
12. De Benedetto A, Kubo A, Beck LA (2012) Skin barrier disruption: a requirement for allergen sensitization J Invest Dermatol 132:949-63
13. De Benedetto A, Rafaels NM, McGirt LY et al. (2011) Tight junction defects in patients with atopic dermatitis. J Allergy Clin Immunol 127:773-86
14. Dombrowicz D, Flamand V, Brigman KK et al. (1993) Abolition of anaphylaxis by targeted disruption of the high affinity immunoglobulin E receptor alpha chain gene. Cell 75:969-76
15. Fallon PG, Sasaki T, Sandilands A et al. (2009) A homozygous frameshift mutation in the mouse Flg gene facilitates enhanced percutaneous allergen priming. Nat Genet 41:602-8
16. Fuiano N, Incorvaia C (2012) Dissecting the causes of atopic dermatitis in children: less foods, more mites. Allergol Int 61:231-43
17. Grewe M, Bruijnzeel-Koomen CA, Schopf E et al. (1998) A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol Today 19:359-61
18. Grimbaldeston MA, Chen CC, Piliponsky AM et al. (2005) Mast cell-deficient W-sash c-kit mutant Kit W-sh/W-sh mice as a model for investigating mast cell biology in vivo. Am J Pathol 167:835-48
19. Gutermuth J, Ollert M, Ring J et al. (2004) Mouse models of atopic eczema critically evaluated. Int Arch Allergy Immunol 135:262-76
20. Irvine AD, McLean WH, Leung DY (2011) Filaggrin mutations associated with skin and allergic diseases. N Engl J Med 365:1315-27
21. Jappe U (2000) Superantigens and their association with dermatological inflammatory diseases: facts and hypotheses. Acta Derm Venereol 80:321-8
22. Jin H, He R, Oyoshi M et al. (2009) Animal models of atopic dermatitis. J Invest Dermatol 129:31-40
23. Kalesnikoff J, Huber M, Lam V et al. (2001) Monomeric IgE stimulates signaling pathways in mast cells that lead to cytokine production and cell survival. Immunity 14:801-11
24. Kawakami T, Ando T, Kimura M et al. (2009a) Mast cells in atopic dermatitis. Curr Opin Immunol 21:666-78
25. Kawakami Y, Tomimori Y, Yumoto K et al. (2009b) Inhibition of NK cell activity by IL-17 allows vaccinia virus to induce severe skin lesions in a mouse model of eczema vaccinatum. J Exp Med 206:1219-25
26. Kawakami Y, Yumoto K, Kawakami T (2007) An improved mouse model of atopic dermatitis and suppression of skin lesions by an inhibitor of tec family kinases. Allergol Int 56:403-9
27. Kim BE, Howell MD, Guttman-Yassky E et al. (2011) TNF-alpha downregulates filaggrin and loricrin through c-Jun N-terminal kinase: role for TNF-alpha antagonists to improve skin barrier. J Invest Dermatol 131:1272-9
28. Kimura M, Tsuruta S, Yoshida T (1998) Correlation of house dust mite-specific lymphocyte proliferation with IL-5 production, eosinophilia, and the severity of symptoms in infants with atopic dermatitis. J Allergy Clin Immunol 101:84-9
29. Kircik LH, Del Rosso JQ (2009) Anti-TNF agents for the treatment of psoriasis. J Drugs Dermatol 8:546-59
30. Kitamura D, Roes J, Kuhn R et al. (1991) A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature 350:423-6
31. Kitaura J, Song J, Tsai M et al. (2003) Evidence that IgE molecules mediate a spectrum of effects on mast cell survival and activation via aggregation of the FcepsilonRI. Proc Natl Acad Sci USA 100:12911-6
32. Konur A, Schulz U, Eissner G et al. (2005) Interferon (IFN)-gamma is a main mediator of keratinocyte (HaCaT) apoptosis and contributes to autocrine IFN-gamma and tumour necrosis factor-alpha production. Br J Dermatol 152:1134-42
33. Kraft S, Novak N (2006) Fc receptors as determinants of allergic reactions. Trends in Immunology 27:88-95
34. Langley RG, Strober BE, Gu Y et al. (2010) Benefit-risk assessment of tumour necrosis factor antagonists in the treatment of psoriasis. Br J Dermatol 162:1349-58
35. Lee JJ, Dimina D, Macias MP et al. (2004) Defining a link with asthma in mice congenitally deficient in eosinophils. Science 305:1773-6
36. Leung DY, Bieber T (2003) Atopic dermatitis. Lancet 361:151-60
37. Li M, Messaddeq N, Teletin M et al. (2005) Retinoid X receptor ablation in adult mouse keratinocytes generates an atopic dermatitis triggered by thymic stromal lymphopoietin. Proc Natl Acad Sci USA 102: 14795-800
38. Lilla JN, Chen CC, Mukai K et al. (2011) Reduced mast cell and basophil numbers and function in Cpa3-Cre; Mcl-1fl/fl mice. Blood 118:6930-8
39. Liu FT, Goodarzi H, Chen HY (2011) IgE, mast cells, and eosinophils in atopic dermatitis. Clin rev Allergy Immunol 41:298-310
40. Liu YJ (2006) Thymic stromal lymphopoietin: master switch for allergic inflammation. J Exp Med 203:269-73
41. Lottaz C, Yang X, Scheid S et al. (2006) OrderedList-a bioconductor package for detecting similarity in ordered gene lists. Bioinformatics 22:2315-6
42. Ma W, Bryce PJ, Humbles AA et al. (2002) CCR3 is essential for skin eosinophilia and airway hyperresponsiveness in a murine model of allergic skin inflammation. J Clin Invest 109:621-8
43. Mombaerts P, Clarke AR, Hooper ML et al. (1991) Creation of a large genomic deletion at the T-cell antigen receptor beta-subunit locus in mouse embryonic stem cells by gene targeting. Proc Natl Acad Sci USA 88:3084-7
44. Mombaerts P, Iacomini J, Johnson RS et al. (1992) RAG-1-deficient mice have no mature B and T lymphocytes. Cell 68:869-77
45. Nakano T, Sonoda T, Hayashi C et al. (1985) Fate of bone marrow-derived cultured mast cells after intracutaneous, intraperitoneal, and intravenous transfer into genetically mast cell-deficient W/Wv mice. Evidence that cultured mast cells can give rise to both connective tissue type and mucosal mast cells. J Exp Med 162:1025-43
46. Nimmerjahn F, Ravetch JV (2006) Fcgamma receptors: old friends and new family members. Immunity 24:19-28
47. Novak N, Leung DY (2011) AdVances in atopic dermatitis. Curr Opin Immunol 23:778-83
48. Oiwa M, Satoh T, Watanabe M et al. (2008) CRTH2-dependent, STAT6-independent induction of cedar pollen dermatitis. Clin Exp Allergy 38:1357-66
49. Okayama Y, Okumura S, Sagara H et al. (2009) FcepsilonRI-mediated thymic stromal lymphopoietin production by interleukin-4-primed human mast cells. Eur Respir J 34:425-35
50. Palmer CN, Irvine AD, Terron-Kwiatkowski A et al. (2006) Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 38:441-6
51. Pasparakis M, Alexopoulou L, Episkopou V et al. (1996) Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J Exp Med 184:1397-411
52. Pua VS, Barnetson RS (2006) Recent developments in the treatment of adult atopic dermatitis. Australas J Dermatol 47:84-9
53. Reber LL, Marichal T, Galli SJ (2012) New models for analyzing mast cell functions in vivo. Trends Immunol 33:613-25
54. Rodewald HR, Feyerabend TB (2012) Widespread immunological functions of mast cells: fact or fiction Immunity 37:13-24
55. Sandilands A, Terron-Kwiatkowski A, Hull PR et al. (2007) Comprehensive analysis of the gene encoding filaggrin uncovers prevalent and rare mutations in ichthyosis vulgaris and atopic eczema. Nat Genet 39:650-4
56. Scalabrin DM, Bavbek S, Perzanowski MS et al. (1999) Use of specific IgE in assessing the releVance of fungal and dust mite allergens to atopic dermatitis: a comparison with asthmatic and nonasthmatic control subjects. J Allergy Clin Immunol 104:1273-9
57. Soumelis V, Reche PA, Kanzler H et al. (2002) Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol 3:673-80
58. Spergel JM, Mizoguchi E, Brewer JP et al. (1998) Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice. J Clin Invest 101:1614-22
59. Stanley E, Lieschke GJ, Grail D et al. (1994) Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Proc Natl Acad Sci USA 91:5592-6
60. Strange P, Skov L, Lisby S et al. (1996) Staphylococcal enterotoxin B applied on intact normal and intact atopic skin induces dermatitis. Arch Dermatol 132:27-33
61. Thepen T, Langeveld-Wildschut EG, Bihari IC et al. (1996) Biphasic response against aeroallergen in atopic dermatitis showing a switch from an initial TH2 response to a TH1 response in situ: an immunocytochemical study. J Allergy Clin Immunol 97:828-37
62. Tsicopoulos A, Hamid Q, Haczku A et al. (1994) Kinetics of cell infiltration and cytokine messenger RNA expression after intradermal challenge with allergen and tuberculin in the same atopic individuals. J Allergy Clin Immunol 94:764-72
63. Vigo PG, Girgis KR, Pfuetze BL et al. (2006) Efficacy of anti-IgE therapy in patients with atopic dermatitis. J Am Acad Dermatol 55:168-70
64. Werfel T, Morita A, Grewe M et al. (1996) Allergen specificity of skin-infiltrating T cells is not restricted to a type-2 cytokine pattern in chronic skin lesions of atopic dermatitis. J Invest Dermatol 107:871-6
65. Wershil BK, Wang ZS, Gordon JR et al. (1991) Recruitment of neutrophils during IgE-dependent cutaneous late phase reactions in the mouse is mast cell-dependent. Partial inhibition of the reaction with antiserum against tumor necrosis factor-alpha. J Clin Invest 87:446-53
66. Woodward AL, Spergel JM, Alenius H et al. (2001) An obligate role for T-cell receptor alphabeta T cells but not T-cell receptor gammadelta T cells, B cells, or CD40/CD40L interactions in a mouse model of atopic dermatitis. J Allergy Clin Immunol 107:359-66
67. Yang X, Bentink S, Scheid S et al. (2006) Similarities of ordered gene lists. J Bioinform Comput Biol 4:693-708
68. Yoo J, Omori M, Gyarmati D et al. (2005) Spontaneous atopic dermatitis in mice expressing an inducible thymic stromal lymphopoietin transgene specifically in the skin. J Exp Med 202:541-9
69. Yu C, Cantor AB, Yang H et al. (2002) Targeted deletion of a high-affinity GATA-binding site in the GATA-1 promoter leads to selective loss of the eosinophil lineage in vivo. J Exp Med 195:1387-95
70. Ziegler SF, Artis D (2010) Sensing the outside world: TSLP regulates barrier immunity. Nat Immunol 11:289-93
71. Zimmermann M, Koreck A, Meyer N et al. (2011) TNF-like weak inducer of apoptosis (TWEAK) and TNF-alpha cooperate in the induction of keratinocyte apoptosis. J Allergy Clin Immunol 127:200-7